Posted on 10 月 1, 202010/1/20
Compliance – The Competitive Differentiator to Commercialization: An Integrated Model Setting the New Global Standard
Posted on 9 月 22, 20209/22/20
NEXT GENERATION COMMERCIALIZATION: A CONVERSATION WITH THE INNOVATORS
Posted on 9 月 21, 20209/21/20
WODC 2020 Insights: Leveraging AI/ML to Advance Rare Diseases
Posted on 9 月 8, 20209/8/20
PharmaVOICE100 Recognizes Two EVERSANA Leaders
Posted on 9 月 4, 20209/4/20
WODC 2020 Insights: Innovative Value and Access Strategies
Posted on 8 月 31, 20208/31/20
Looking To Launch Or Commercialise In The US?
Posted on 8 月 28, 20208/28/20
The Chronic Microcap Trap: How Launch Is The Escape for True Growth
Posted on 8 月 20, 20208/20/20
The New Gold Standard of Drug Commercialization
Posted on 8 月 14, 20208/14/20
Improving Patient Outcomes Through Digital Health
Posted on 8 月 10, 20208/10/20